N
Google TrendANNA BONDAR (200+) — October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Early Trial Data Show Pro" (30 stories)

Top Headline Story

Alkermes (ALKS) Reports Early ADHD Drug Results. Can a Larger Trial Show it Works?
Lead StoryYahoo Financegeneral
Sep 25

Alkermes (ALKS) Reports Early ADHD Drug Results. Can a Larger Trial Show it Works?

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQcnRLb29tMGUyMF9sRFZXQkxuRTlTT3N3OUJFNTBCekVMaFNoUUFEaXpfRU5ITlktZWMwcEVaeTdUaXlyWXlsV1Itb19PUlFoWmFkQzR2MmF5X2cwcTRrYnJIT0UwTUhmQzR5WGRDTFc2bV9ZcF8zSTJVMDJOekJYdU1hNHlXZTBQcjQ0bGx3dG83WjdmRDFqRg?oc=5" target="_blank">Alkermes (ALKS) Reports Early ADHD Drug Results. Can a Larger Trial Show it Works?</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+18m ago

anna bondar

October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market

Filter stories
100+18m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+28m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+28m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "Early Trial Data Show Pro"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Briumvi outperforms Aubagio when given as first MS therapy, per trial data
Multiple Sclerosis News Todaygeneral

Briumvi outperforms Aubagio when given as first MS therapy, per trial data

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPLXR5OUtIR3dDUFhHM3Uwa0RURFljSnRmTDk5eDRqVnVXejZZd1pHN0FvcmJnc19yQ3M3eHVmVnJvdXRpWmRXRUlaTGtiMzhaR1JMaGZTaUJuVmlNMy0yZjZudF9iYmFUcFhxMGR5RHQ5MHJ6bUlCT0xGSzZqNXpNcVZSemxfY0pubmdoa3lRcE5pam9XVjROWDJlX1VjWnZPOXkwcEZ3NnM0S0hQNE9XUnA2VXNLMWhwek90MHhoRjBsdw?oc=5" target="_blank">Briumvi outperforms Aubagio when given as first MS therapy, per trial data</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

Read Full StoryMore like this
SKY-0515 data suggest slower progression in Huntington’s disease
Huntington's Disease Newsworld

SKY-0515 data suggest slower progression in Huntington’s disease

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOd1hKR3BlelJVdWJocDdqNlFBMVNlRG9ndkk2bUJMSll2Zmx5SEoxdXJCSW5yTnEwa1hDdW1rZmxjV0JXdW9oNXBxdm1PSGRwNEVzcVhuaWxpTUtxbTdVNTg3VmJjMTVhdHo2bHZyTHlTX0xjeG4yWkkyQkNXeXZHRm5ZeUphalVubHpHN3JtaHE4MGhTbmxjTk5UQmtGNlBabEE0?oc=5" target="_blank">SKY-0515 data suggest slower progression in Huntington’s disease</a>  <font color="#6f6f6f">Huntington's Disease News</font>

Read Full StoryMore like this
Results Show Fewer Early-Phase NSCLC Trials, Locations Since 2022
Cancer Therapy Advisorgeneral

Results Show Fewer Early-Phase NSCLC Trials, Locations Since 2022

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPSEdham5zb19NYWhmNkJNNldtWDdWZlY2UXFIWHAyYUgxWVNpdk51cFlTVTdmYXliWnFvWWhIWmh2TXBJTlhsZ0ZuYndmVDF6TjZUX0dLcDZGaHFheVpCZ2JOR05jVlB3RC1UN3JSbTM2bm9VenZiSkZoZHJuS3NYdUZYN25GMlNMZHRV?oc=5" target="_blank">Results Show Fewer Early-Phase NSCLC Trials, Locations Since 2022</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Read Full StoryMore like this
TULSA vs. Surgery: Prostate Cancer Trial Shows Early Positive Results
Yale School of Medicinegeneral

TULSA vs. Surgery: Prostate Cancer Trial Shows Early Positive Results

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeXJ5ajN6aEhPcFdkZG1DdFJzbGNMbXBOcmt1QXFibWRWdGtBMlNwdEdveEdNVk5YT251Nk1zeWt3bFA1cVZlRnBQM2l2Q2xsdDJiN0ViU3pFVGRGbVlfOVRNcDl1NjFabXU5dVc3cHUwNU9kXzNqZGFxV3JIamgwVWJmN0RlQXJwTFZtQlp5YnVKRE5Rd1h5OHlReVRYUWxNZVZmNlVBOEhWdzA?oc=5" target="_blank">TULSA vs. Surgery: Prostate Cancer Trial Shows Early Positive Results</a>  <font color="#6f6f6f">Yale School of Medicine</font>

Read Full StoryMore like this
‘Great results’: Vic farm trial shows early promise
The Weekly Timesgeneral

‘Great results’: Vic farm trial shows early promise

<a href="https://news.google.com/rss/articles/CBMi9gFBVV95cUxNcnJDUzMycGkyU2QwUlNUZS1fRmd2T1l0NG9Xelh1d0VZbWNoSy1pV21rYjZRVnd5Nl9mbFZQZ0xxRGVtYlQ5RFVrR2RKV1RXamNVd1ZMU051bUtLcE9MUXdSMWNWSWRfRUNHN2tmcG5DT243VHpEb3FieGd6ZnNfekJHSHBhM1dJVkdKeUxDXzFKLTFVVkY1b3lIWXFSVElDdENrMDBqbmtTdkFlZFZodnJ4c2QtUnQ0X1RxLTUzUTAwUzVIa09mSG5nVGdIYXFXbW80VU1hSDUxWC1xQXNzTUVjVWt4MWExVjFWcTBGTGZGZFYxM2c?oc=5" target="_blank">‘Great results’: Vic farm trial shows early promise</a>  <font color="#6f6f6f">The Weekly Times</font>

Read Full StoryMore like this
First Patient Dosed in VIR-5500 T-Cell Engager Trial in Metastatic Prostate Cancer
Targeted Oncologygeneral

First Patient Dosed in VIR-5500 T-Cell Engager Trial in Metastatic Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPWlVFVkFFeDZaVUJ6c0JBVmM1YTBJaXlHdUVMamtKMzlLclp3c1dmRllocF9zaHNpSkFxTGNKZGsxNkI0SzZ1cHJRYkhmdEF2bFRHbm1LSVhTdjZVQzlzQXB3MUQ2WmJFZnNlYUprdTlwZ2N6cTJxQ0Y1dFRGcGtpc0ppR19uUUJpcDQtUDk1d1lwS291OGFaY09NQ2piZ3F6U1FZeXlkVTJfQjh4Z2pqQmgtS1hwZw?oc=5" target="_blank">First Patient Dosed in VIR-5500 T-Cell Engager Trial in Metastatic Prostate Cancer</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Early Clinical Trial Results Show Promise for Glioblastoma Immunotherapy
Harvard Medical Schoolworld

Early Clinical Trial Results Show Promise for Glioblastoma Immunotherapy

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNLURzaWZzUl90MGFHS043MDUwVmIwZjZUTEV3UTJ0VTZkbjhERnNRdHJWZEY3Rlh5Tkg1YmFYT3VVblVLb1ZSWVdhN3kxa2FMMGdaWUJZM2FrLTFENEpjSzNCMUcxekhIdFRkbzZnOVhlOHBLTlJETzRoOTZKMHBlZ0I5SXBIVVY3ZU1SSzVNeDhfTmx3YXpVZHZjRUdBUQ?oc=5" target="_blank">Early Clinical Trial Results Show Promise for Glioblastoma Immunotherapy</a>  <font color="#6f6f6f">Harvard Medical School</font>

Read Full StoryMore like this
New trial data show early biological signals for Parkinson’s therapy
Parkinson's News Todaygeneral

New trial data show early biological signals for Parkinson’s therapy

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQaW9FREdtTlNRY2VkdTJCUUZQNkVDVHllU2JMbm5sdUdpZkFNc0ZKSTFOLTBvSnhZblJ6OGF6NFNXd0ZWUmhYSjRaZU1MYnRKMjB2YzF1NlFPMUxBRllyWmZEaTRjSUx4UFhjTlBKYU1LaE9udXpPRThCbmZiUi1OMGxfeUZNRFRPM2xnOFZPQWJPWVBucGFKOGpycVREZw?oc=5" target="_blank">New trial data show early biological signals for Parkinson’s therapy</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
Early trial data support RNA therapies for two muscular dystrophy types
Muscular Dystrophy Newsgeneral

Early trial data support RNA therapies for two muscular dystrophy types

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNalVJQlFFQ1luWTlnNDdETGdJdDJoUGFoOGlJa0NxVktjVk9tLTlTRjFhSjFUVDVkRGdISjdXeEp0RE8tSE5tb19DaVY5RHduSmIxVEF1cGFxTmF1M0lNQURHV2F6X0RPTnZuaGtiX21yb2l3SjFGaENmSHoxLXBibE5XU0VVUXlHMlh5M0RjTjlaQ3J2T1ZLNGhQOHQtWHZlbzNr?oc=5" target="_blank">Early trial data support RNA therapies for two muscular dystrophy types</a>  <font color="#6f6f6f">Muscular Dystrophy News</font>

Read Full StoryMore like this
Olvi-Vec Shows Early Activity in Small Cell and NSCLC Trials
Cure Todaygeneral

Olvi-Vec Shows Early Activity in Small Cell and NSCLC Trials

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQNmQzQ3JlWnFlVXdlN05kSnplc2V1SnNCWENYQmZHRDMxZGdTZS1XcWszcm0tWmRDMWRhQ1dSNXpNRG13cEFnQ2NIVFNUVEpMZFZGS2V2c1BtNVFMaEtYTkxQU2NzM3hvZEVTbEh3b1pMejNRQVdoa3p2STBiZ1lEdDBVYloxSnY5TGF5MzJIbW9oak1HRnc?oc=5" target="_blank">Olvi-Vec Shows Early Activity in Small Cell and NSCLC Trials</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
Early Trial Data Show TROP2-Targeted ADC DB-1305/BNT325 Activity in TNBC: Erika Hamilton, MD
AJMCgeneral

Early Trial Data Show TROP2-Targeted ADC DB-1305/BNT325 Activity in TNBC: Erika Hamilton, MD

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNcWF1Nk1DS240WWlsWnNURFpZYXZzQnFxYThwc0lrdklkYUo5cmVJQTR2LU1xc1FyTXl6V1RoV1ZUZ1BEUy1fLVJxUzg5UmpaZlJTM1U0MGM2Z0ZvTlAzZjVpM3g3bGdsOHpIa2pDNWRFNElaTXNrcWVCZWZEZ0pYNVlLb3Z5dUVIR0p5bEFhUHJYdw?oc=5" target="_blank">Early Trial Data Show TROP2-Targeted ADC DB-1305/BNT325 Activity in TNBC: Erika Hamilton, MD</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
CF gene therapy 4D-710 shows signs of improving lung function in early trial
Cystic Fibrosis News Todayworld

CF gene therapy 4D-710 shows signs of improving lung function in early trial

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNc04tVXNOSGFZUnY0RDJjMkk5VjFrVl9DdHhhRS1YQUlmV0xkbl8weGpCQWFIWlRGNVAtMG1FaWlHTkFyaU1jS0NNM1RrazRFamFqR3NsVlJuQnh3V05wVFZYYTVuZVVaalZiVEFYS0hJMW03Q3BsVWFIN3hjZGVoVHF3ZW80VEJGR2xIRld2Mk5mcnRaNzhvWmhSVzJzdEk?oc=5" target="_blank">CF gene therapy 4D-710 shows signs of improving lung function in early trial</a>  <font color="#6f6f6f">Cystic Fibrosis News Today</font>

Read Full StoryMore like this
Dravet syndrome gene therapy shows promising early data in trial
Dravet Syndrome Newsgeneral

Dravet syndrome gene therapy shows promising early data in trial

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOaHNpdmZpYjFjbm5sazFEWk5EZVVDTS1JWjEtcHlPSTkyU3g4LXR3dGdlSTA0d2JLRTJpRjNkbENFdmhUOFE4bXVFUkV3SXBMWV9oUEVXS3N2dVBUczg5bWplRGRXYXo1d2NGVHJISzFqWkZYV3BUMlVyOHhxYTU0YV85aXFDbDVtWVdhRE1MRWRkTlVEazRhZ1JTX1J0Rnc?oc=5" target="_blank">Dravet syndrome gene therapy shows promising early data in trial</a>  <font color="#6f6f6f">Dravet Syndrome News</font>

Read Full StoryMore like this
Early Clinical Data Show KRAS Inhibitors Can Work in Cholangiocarcinoma
CancerNetworkgeneral

Early Clinical Data Show KRAS Inhibitors Can Work in Cholangiocarcinoma

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbm9Sc3RnTDl0OU9WdkgtSjlWTEJRZ1ZveVA0elFpZjd4bkNNYU5nYy0ybGl4SGZGa1h3QjdOaEV6WVJLcEVxbGlWTFZFTGFpSHc5aUlMbGFPVjZGUlJlbHJVUzNoUmJJb3FDQ2djVGIwNzRadnc5VmJSc01RUGJYMDI0TC05cnEzbW95OTVoRkUtaUxMSXVsTHltbmp0VkRnVm1yOXBjVzFxQQ?oc=5" target="_blank">Early Clinical Data Show KRAS Inhibitors Can Work in Cholangiocarcinoma</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Selpercatinib Shows Promise as Adjuvant Therapy in Early-Stage NSCLC
Oncology News Centralgeneral

Selpercatinib Shows Promise as Adjuvant Therapy in Early-Stage NSCLC

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOTjJKMG9pWk41SjRUUkhIbmlWcmlMQWwyMnFEelY1UlJ6anhOTHVKcUJrY3FPaFRpSE5RNzMwTHdlQzBUa1dyMk5JNHV3Z2RyWnF2SUFZQlhnR0RocGg5cXdXSEJJTC13dy02RE5HWnEzbnBHZTQtX1MyMGJhWkp4RG9GejZMbHRDYlN1ZnE0REpPbVRQV2VadHFmV3FfTVREZ0VhdXBB?oc=5" target="_blank">Selpercatinib Shows Promise as Adjuvant Therapy in Early-Stage NSCLC</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
Pancreatic Cancer mRNA Vaccine Shows Promising Results in Early Clinical Trial
Pharmacy Timesgeneral

Pancreatic Cancer mRNA Vaccine Shows Promising Results in Early Clinical Trial

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQaUN5RHlZanoycFN5NzVwRG42cXR3dG5QNHJHWTN4RGp5OUlGOWtzd2FHMHRFZk5LcmkyZjZkUmt3UzR5eDFpRzJubGlxcDRaVWhVZWNoN1o2T2dJSS05VjZSSkNiTXRQRm5iUTdKQldRUThPNml4VWhNaGx0VjlQQzBLbkFnc1FuY2YtMlRhbjZCV0poWl9JSURkWVFjVklUM3BuRFFmQlBFMTdMa3ZUbzhQWQ?oc=5" target="_blank">Pancreatic Cancer mRNA Vaccine Shows Promising Results in Early Clinical Trial</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Huntington’s treatment safely slows disease over 9 months in early trial
Huntington's Disease Newsworld

Huntington’s treatment safely slows disease over 9 months in early trial

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPc2hHc1N4Y2dLTVRJVFpSbDJMekU5NkI3R3lla2JiTHZhSmV6RTR1T2ZaQUlDQ3RDNFFCV2FCanJkTEVaek9PR0oyWVp3NEVCRV8xZGJWcUpXbG9aMFF1NlVJQV9yTDZvMkZwUFMtbTRJQWRnNlJ0ZU05WFExSEJqTkpGTVJfbEdoVzZ6aHBvVUtqd1FDNFRkYnZWWjNMY1EzbzZhNU5lRHRlYW0y?oc=5" target="_blank">Huntington’s treatment safely slows disease over 9 months in early trial</a>  <font color="#6f6f6f">Huntington's Disease News</font>

Read Full StoryMore like this
ANPD001 eases motor symptoms, early trial data show
Parkinson's News Todaygeneral

ANPD001 eases motor symptoms, early trial data show

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPZzVFOWthTkVVSDJuUVhfZ2RjYzAwamFmQXVvMWx2MFR6MmtVdWlIZm5QWnBuSnRxZnVGeW5uVEtPQUctZTBiRlU1M0VrOXNVTzVBSTkxLTJBbVAxUHh6Ymw2UTVXLXdJMm9VdVlCUkxWUXRjWGwwN1k4TENpUVp1a05BSWlOWDRQX2tRYWxQMU5RUQ?oc=5" target="_blank">ANPD001 eases motor symptoms, early trial data show</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
Preoperative Radiation Plus Pembro Shows Benefit in HR+, HER2– Breast Cancer Trial
Oncology News Centralgeneral

Preoperative Radiation Plus Pembro Shows Benefit in HR+, HER2– Breast Cancer Trial

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxOOTRnNFdZeU1pMG5NZVBZVUxMWDhZQ1hyd0lCMTJxZHdoY2hBaVgtZ09PYXRWS3cwSnFIN0RSOTVzSGdKUVdyTTZHU0RsWHJzdk0tWVB3WWNrQXJKYXA1MFpfQUk2bkFfcmNDX3o2TkdKZUE1ZUtrTDVVRENvbXVyNFZDYUt1MzJ5V3RlVHZXamhwN2FDaGNvTTh2eUJkdFE5dUZrU21aaW5mTGxhUExxVlB2MWNXV0VHQXpudjZQWUtzUlFLekNBd2stOEFlc0pzR1lfNFBVS1IzbVZsaDFDVQ?oc=5" target="_blank">Preoperative Radiation Plus Pembro Shows Benefit in HR+, HER2– Breast Cancer Trial</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
First Therapy Chatbot Trial Yields Mental Health Benefits
Dartmouthscience

First Therapy Chatbot Trial Yields Mental Health Benefits

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNMWJjbWx5c3U4YzVia2MybjByTEtQdUJHWEZydzNodENkanlBT0g2VGNOUi1WMkc4MGJ5Z0Q2WXRRNm1TaEJxMHRKclpZQVJISlBnY2w0X05QaHR3RTlsVlNrNm51RUFicE1NRTVpU1V4ZFVQV3JXQlg4UDF2LUZCWFdJejNxTV83UVhoRVk3TTkzd00tOTlTdTZ5T2hCQQ?oc=5" target="_blank">First Therapy Chatbot Trial Yields Mental Health Benefits</a>  <font color="#6f6f6f">Dartmouth</font>

Read Full StoryMore like this
Measuring the Impact of Early-2025 AI on Experienced Open-Source Developer Productivity
METRtech

Measuring the Impact of Early-2025 AI on Experienced Open-Source Developer Productivity

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE84VnVlUW1fUF9FaXNvbFpDMEU4bl81WGVMUUwydUh2cnByYlhZMDl3SFlpSXBHaUVqTk00SEtMQjVMMkROYl9wVFBXbmNYS21XRlhFNmJlbG51d29WLXZtN2hFQ09IQWFkUXQ5R2piRmN5QjVxWHd3MW45QmQ?oc=5" target="_blank">Measuring the Impact of Early-2025 AI on Experienced Open-Source Developer Productivity</a>  <font color="#6f6f6f">METR</font>

Read Full StoryMore like this
CAR T-cell therapy eases SSc symptoms, early trial data show
Scleroderma Newsgeneral

CAR T-cell therapy eases SSc symptoms, early trial data show

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOVzMtYzJjNjdMdkREQUJ0TUVjNk9DN1R0Y3pkc01mZEc1ZkNkQk4xMEJzMk9xSzlQQTFqVHU2dTZ2aUpldFBic2kxbTUtUDZ1MTVtV0IwbzlDTjg3eFRyQkhtMmtsRExFRjN0R2c3LUlYeldyaWhxak41NmJtems2WDBuSjl5bjdxSmI5dDVDTTdRcnpCSUdYTQ?oc=5" target="_blank">CAR T-cell therapy eases SSc symptoms, early trial data show</a>  <font color="#6f6f6f">Scleroderma News</font>

Read Full StoryMore like this
Gene-editing therapy PBGENE-HBV shows encouraging trial results
Liver Disease Newsgeneral

Gene-editing therapy PBGENE-HBV shows encouraging trial results

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNRkd2M1M5bDRfdkpSczJVNlpoLXp6dWlxM1plRmZmVWhWMVk3eXFZM2dnaXJoRFctekZlTGI4aHpza01GdllXTjVBa0hDTDAtTDI1OWxlU3hWai15amJqUW1sSE5kOWpkNHdTOFpZSTNwbFZpTHNLSkd1UDNTZFpxZTR1TnVWTzZwcjhzLVRiS2o0VGRCRkpn?oc=5" target="_blank">Gene-editing therapy PBGENE-HBV shows encouraging trial results</a>  <font color="#6f6f6f">Liver Disease News</font>

Read Full StoryMore like this
PRO Analysis Finds Manageable AEs With Olaparib in Early Breast Cancer
CancerNetworkgeneral

PRO Analysis Finds Manageable AEs With Olaparib in Early Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOTEZYN3ozRWV5M2xBRU9ZSWFobldfdWtuUmtOV0hLamJWZXdqdGJUbzhzaWFrQkw1UldwalNsNU5Dd0hnUHRZNV9UeHp0RnFXTGVnSU1oWmdRV2x5MDBOV0FseXJqdm9YSFBLWnJLM0FuckdJNVFFdHlicDZnbllJNHNhUFBGODZ2aFlFRU82YVhKOVFiVmh0OHozNXV0V3dMME13OE9MT3E?oc=5" target="_blank">PRO Analysis Finds Manageable AEs With Olaparib in Early Breast Cancer</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
ARCT-032 well tolerated in CF trial with early positive signs
Cystic Fibrosis News Todaygeneral

ARCT-032 well tolerated in CF trial with early positive signs

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQMlFzU2p4UHNMYUNzQ0x1MHg3ZVNma0t4clNiV3VYSjJIV0U5Q0dNdXp4d3hyaXZfcUxwVDUtdWtJTElxZFlULU91bS1kSkIyMlprenNmb0hmeU9fbTFCQm90dTExZkhpR1RFNmxQdE5PblpjcVNoYlE0ZGswQklPcXQ3TWdOSktyRUN0bnhmcTZwWVpxS0k1aU0wcw?oc=5" target="_blank">ARCT-032 well tolerated in CF trial with early positive signs</a>  <font color="#6f6f6f">Cystic Fibrosis News Today</font>

Read Full StoryMore like this
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
The Lancetgeneral

A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcVkwbjBNT0ZXckp3Zk5uWlllckhPY3E3S0F2OVZ5VXoxQ1ptTkt2QTdXTjJfc1ltcktXM2NwLWJtSnhTZTAzanFvc0poYlpSYUpYV1p4NGJaWUxkYy05ZzhrVzVmLUlVY2pnOURLdG56bkwyMWxHd2hkVkZyWURZZW9kSE9WQVRhbWpv?oc=5" target="_blank">A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
AOC 1001 Eases Symptoms of DM1, Early Clinical Trial Data Show |...
Muscular Dystrophy Newsgeneral

AOC 1001 Eases Symptoms of DM1, Early Clinical Trial Data Show |...

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPakJBeFA2X3Z2WUtJR2t5RXZ0ZjVCcGVsX2RNX1IyZ1V3bzUzMlRaSXV1YXZVQzVmNFBiOGJHem85NlBxNmFuNFI0STM4SEhGLWVab1A4NlBqOVpEb3k4VXFLc0pwVkMxUWFKcHlZXzVxa0doSzV1WS1YOHJGbUF1ZkI5R1VnN3NyNHV4ZkpXVTJoc1U?oc=5" target="_blank">AOC 1001 Eases Symptoms of DM1, Early Clinical Trial Data Show |...</a>  <font color="#6f6f6f">Muscular Dystrophy News</font>

Read Full StoryMore like this
Fixed-Duration Triplet Produces “Compelling” Results in Phase 2 CLL Trial
Oncology News Centralgeneral

Fixed-Duration Triplet Produces “Compelling” Results in Phase 2 CLL Trial

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPcDVOd3NhN0N1S3BBdi1ycFppSjJxU3IwV1FLTmNZbUNPNXdjOTI5MkdYLVpRazVZWldHSFJ0YWxqeHlKNkI1WDhTV3h1Smxxb1RFY0JJU2NKUWxlc3NXOVVJWjRldUZDRmQzUnNYUE84TzJmaE85NDcyZmR2ZXRBaUpCa1FMTnZJYVBwTVlGTFV0RGpmUzdXVVN4YzBDc3pkSEtOOXI4MndDcnU3Y2J5TA?oc=5" target="_blank">Fixed-Duration Triplet Produces “Compelling” Results in Phase 2 CLL Trial</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
Early trial data suggest GT-02287 may ease Parkinson’s symptoms
Parkinson's News Todaygeneral

Early trial data suggest GT-02287 may ease Parkinson’s symptoms

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOTDhxTXdma1ZHNjlod2liYWNXOFplbEVGVjR6elJmbWdZRXNTY1ViU1pwR1o0NDF2TjdQS1I3WDBPc1JTU3h3UHdsNGJDbVdSR2tPMmhDVFpQalNSOXN0X3hBNV94NEhJWGkwUVhYbDBEc1VrLTFoc0MxV2hzbHUwSTlLWHpyRlhiVXRUZ0JzT2ktYTRJM2JPdmw0Zw?oc=5" target="_blank">Early trial data suggest GT-02287 may ease Parkinson’s symptoms</a>  <font color="#6f6f6f">Parkinson's News Today</font>

Read Full StoryMore like this
"Early Trial Data Show Pro" — Live Google News Trends & Headlines